logo

Regeneron Pharmaceuticals (REGN)



Trade REGN now with
  Date
  Headline
2/6/2020 6:31:36 AM Regeneron Q4 GAAP EPS $6.93 And Non-GAAP EPS $7.50
2/4/2020 9:02:44 AM Regeneron Pharma Expands Agreement With HHS To Develop New Treatments Combating Novel Coronavirus, 2019-nCoV
1/28/2020 1:00:33 AM Regeneron Pharma And Sanofi: FDA Accepts For Priority Review The SBLA For Dupixent
1/9/2020 7:01:42 AM Regeneron Announces Encouraging Garetosmab Phase 2 Results In Patients With Ultra-Rare Debilitating Bone Disease
12/10/2019 8:40:08 AM Sanofi And Regeneron To Restructure Antibody Collaboration For Kevzara And Praluent
12/10/2019 8:31:53 AM Regeneron, Sanofi To Restructure Antibody Collaboration For Kevzara, Praluent
12/5/2019 7:02:07 AM Regeneron Reports Positive Topline Phase 2 Data With Anti-C5 Antibody Pozelimab In Patients With Rare Blood Disorder
11/6/2019 7:06:05 AM Regeneron, Vyriad Announce Strategic Agreement For Development Of New Oncolytic Virus Treatments For Cancer
11/5/2019 6:43:00 AM Regeneron Updates On Phase 3 Libtayo Development Program In Advanced Non-small Cell Lung Cancer
  
 
>